Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Biotech Jim who wrote (3906)	5/29/2001 5:10:40 PM
From: Biomaven	Read Replies (3) \| Respond to of 52153

Anyone have any idea of why GZMO has been so strong the last 6 weeks or so? I think it's been my best performing stock of late, but I haven't a clue why. Peter

To: Biotech Jim who wrote (3906)	5/29/2001 7:39:35 PM
From: Michael Young	Respond to of 52153

No relationship to Cramer. But I get a little peeved when investors deride professionals with great long term track records, simply because they sometimes give bearish opinions. I believe Cramer averaged over a 28% return for better than a decade. That is excellent. The entire street machine is geared up for hyping stocks. Biotechs in particular are susceptible to analyst nonsense. I recall reading an analyst report from a major firm last fall predicting that MXIM had an 80% chance of getting the melanoma drug approved. Meanwhile thestreet.com was plugged into the hedge fund shorts saying the drug was a dud. CLPA is another good example. I find that kind of stuff invaluable. Again, if any of the guys on this thread think they are better than Cramer they should open up their own hedge fund. You can get going for around $25k in legal fees. Bank of America and Furman Selz provide excellent support to fledging hedge funds. MIKE